GB702269A - Tertiary allylamines of therapeutic value and the production thereof - Google Patents

Tertiary allylamines of therapeutic value and the production thereof

Info

Publication number
GB702269A
GB702269A GB42350A GB42350A GB702269A GB 702269 A GB702269 A GB 702269A GB 42350 A GB42350 A GB 42350A GB 42350 A GB42350 A GB 42350A GB 702269 A GB702269 A GB 702269A
Authority
GB
United Kingdom
Prior art keywords
thienyl
methyl
ene
reacting
diethylamino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB42350A
Inventor
Donald Wallace Adamson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Priority to GB42350A priority Critical patent/GB702269A/en
Publication of GB702269A publication Critical patent/GB702269A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)

Abstract

The invention comprises as new compounds having strong analgesic properties, 3-methylethylamino-1 : 1-di-(2-thienyl)-but-1-ene or a salt thereof and 3-diethylamino-1 : 1-di-(2-thienyl)-but-1-ene or a salt thereof. The compounds may be prepared by treating the corresponding aminoalkanols with a dehydrating agent to remove the elements of water. The aminoalkanols may be prepared by reacting together an alkyl ester of the formula: <FORM:0702269/IV(b)/1> in which NR2R3 is a diethylamino or methylethyl-amino group and R4 is an alkyl radical, or a salt thereof, and 2-thienyllithium or the organo - magnesium compound derived from 2-bromothiophen and then hydrolysing the organo-metallic compound so formed. Alternatively the aminoalkanols may be prepared by reacting a 2-thienyl b -aminoalkyl ketone of the formula:- <FORM:0702269/IV(b)/2> in which <FORM:0702269/IV(b)/3> is as defined above with 2-thienyllithium or the organo-magnesium compound derived from 2-bromothiophen and then hydrolysing the organo-metallic compound so formed. In examples: (1) thiophen in anhydrous ether is added to an ethereal solution of n-butyllithium prepared from n-butyl chloride, lithium and anhydrous ether, and the mixture boiled under reflux in a stream of nitrogen. Methyl b -methylethylaminobutyrate is then added gradually with stirring and cooling to -20 DEG C. Stirring is then continued at room temperature and ice added followed by glacial acetic acid until the solution is acidic to litmus. The precipitated white solid is filtered, washed with ether, suspended in chloroform and treated with excess ammonia and 3-methyl-ethylamino-1-1-di-(2-thienyl)-butan-1-ol isolated from the chloroform extract. The aminoalkanol is then warmed with concentrated hydrochloric acid and glacial acetic acid, the solution poured into water, extracted with ether to yield the product 3-methylethylamino-1:1-di-(2-thienyl)-but-1-ene the hydrochloride of which is also described; (2) ethyl b -diethylaminobutyrate is reacted with a solution of 2-thienyllithium in ether under conditions similar to those of (1) to give 3-diethylamino-1:1-di-(2-thienyl)-butan-1-ol the acid oxalate of which is also described. The aminoalkanol is then heated with 6N hydrochloric acid, the solution cooled, excess ammonia added and the mixture extracted with chloroform to yield 3-diethylamino-1:1-di-(2-thienyl)-but-1-ene, the hydrochloride of which is also described. Specification 657,301 is referred to. Methyl-b -methylethylaminobutyrate is prepared by reacting methylethylamine and methyl crotonate in methanol at room temperature. The first Provisional Specification describes the production of the diethylamino compounds and of 3-N-pyrrolidino-(and 3-N-piperidino-)-1:1-di (21-thienyl) but-1-ene and 3-diamethylamino-1:1-di (21-thienyl) hex-1-ene and the corresponding aminoalkanols by similar methods and states that the aminoalkanols may be converted to water-soluble salts by treatment with acids such as hydrochloric, hydrobromic, phosphoric, maleic, mucic and succinic acids. It also states that the dehydration of the amino alkanols may be effected by reacting them or their salts with mineral acids, carboxylic acid chlorides and carboxylic acid anhydrides and the acid oxalates of the aminobutanol derivatives as well as the hydrochlorides of the tertiary allylamines are described. The preparation of methyl b -N-pyrrolidinobutyrate by reacting methyl crotonate with pyrrolidine and of methyl b -dimethyl aminocaproate by reacting methyl-b -norpropylacrylate with dimethylamine are also described.
GB42350A 1950-01-06 1950-01-06 Tertiary allylamines of therapeutic value and the production thereof Expired GB702269A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB42350A GB702269A (en) 1950-01-06 1950-01-06 Tertiary allylamines of therapeutic value and the production thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB42350A GB702269A (en) 1950-01-06 1950-01-06 Tertiary allylamines of therapeutic value and the production thereof

Publications (1)

Publication Number Publication Date
GB702269A true GB702269A (en) 1954-01-13

Family

ID=9704093

Family Applications (1)

Application Number Title Priority Date Filing Date
GB42350A Expired GB702269A (en) 1950-01-06 1950-01-06 Tertiary allylamines of therapeutic value and the production thereof

Country Status (1)

Country Link
GB (1) GB702269A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1194424B (en) * 1961-11-10 1965-06-10 Degussa Process for the preparation of basic thiophene derivatives
DE1199783B (en) * 1962-11-30 1965-09-02 Degussa Process for the preparation of basic thiophene derivatives
DE1219038B (en) * 1962-12-08 1966-06-16 Degussa Process for the preparation of thiophene compounds

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1194424B (en) * 1961-11-10 1965-06-10 Degussa Process for the preparation of basic thiophene derivatives
DE1199783B (en) * 1962-11-30 1965-09-02 Degussa Process for the preparation of basic thiophene derivatives
DE1219038B (en) * 1962-12-08 1966-06-16 Degussa Process for the preparation of thiophene compounds

Similar Documents

Publication Publication Date Title
US7238815B2 (en) Process for the industrial synthesis of the methyl diester of 5-amino-3-carboxymethyl-4-cyano-2-thiophenecarboxylic acid, and application to the synthesis of bivalent salts of ranelic acid and their hydrates
NO141487B (en) WIRELESS INFORMATION TRANSMISSION SYSTEM
SU419023A3 (en) METHOD FOR OBTAINING ACYLIC XYLIDIDES
CZ393999A3 (en) Process for preparing pharmaceutically active substance
SU504480A3 (en) Method for producing amides of (1 (-phenylalkyl) -piperidyl-4 -) - (-pyridyl) -carboxylic acid or their salts
GB702269A (en) Tertiary allylamines of therapeutic value and the production thereof
NO122370B (en)
US2425721A (en) Thiophene compounds and methods of obtaining the same
FI59086B (en) FOERFARANDE FOER FRAMSTAELLNING AV 2,5-DISUBSTITUERADE BENSAMIDER
GB657301A (en) Improvements in and relating to the preparation of substituted amino-alcohols and derivatives thereof
US2519530A (en) Biotin aliphatic amides and method for their preparation
US2406627A (en) Alkamine derivatives of para aminomethyl benzoic acid
JPS6230192B2 (en)
NO135092B (en)
US2543764A (en) Diaralkyl carbinyl esters of dialkylamino alkanoates and the production thereof
CN109456170B (en) Preparation method of calcium levulinate
CN106008388B (en) A kind of preparation method for the SC 69124 for being used to treat postoperative pain
US3759909A (en) Fumaramic acid derivatives
NO136460B (en)
SU422137A3 (en) METHOD OF OBTAINING 1-
US2428239A (en) Alkamine derivatives of meta aminomethyl benzoic acid
FI71299B (en) FOERENING ANVAENDBAR SAOSOM MELLANPRODUKT VID FRAMSTAELLNING AV THERAPEUTISKT VAERDEFULL 2- (6-METOXI-2-NAFTYL) -PROPIONSYRA
SU512696A3 (en) Method for producing benzylamines
SU374304A1 (en) METHOD OF OBTAINING SOVKAIN - UZ-DIETHYLAMINOETHYLAMIDE HYDROCHLORIDE 2-BUTOXYXYNHONIN
KR850001036B1 (en) Process for the preparing of an amide of 2-amino-4-methylpyridine